首页> 外文期刊>European review for medical and pharmacological sciences. >Expression level of miRNA-210-3p in cervical cancer and its prognostic potential
【24h】

Expression level of miRNA-210-3p in cervical cancer and its prognostic potential

机译:宫颈癌中miRNA-210-3P的表达水平及其预后潜力

获取原文
       

摘要

OBJECTIVE: The purpose of this study was to detect the expression level of microRNA-210-3p (miRNA-210-3p) in cervical cancer (CC) tissues and its clinical significance. PATIENTS AND METHODS: Expression levels of miRNA-210-3p in collected CC tissues, normal cervical tissues and cervical intraepithelial neoplasia (CIN) tissues (CIN I, CIN II, and CIN III) were tested by reverse transcriptase-polymerase chain reaction (RT-PCR). The relationship between miRNA-210-3p level and clinical data of CC patients was analyzed. Moreover, the receiver operating characteristic (ROC) was introduced for assessing the diagnostic potential of miRNA-210-3p in CC. RESULTS: Results revealed that miRNA-210-3p level was higher in CC tissues relative to normal cervical tissues and CIN tissues. Its expression was not correlated with age, pathological subtype, and tumor size of CC patients. However, miRNA-210-3p level was closely linked to FIGO stage, tumor differentiation, and lymphatic metastasis in CC. Based on depicted ROC, miRNA-210-3p was able to distinguish CC from normal cervical tissues and CIN tissues. CONCLUSIONS: MiRNA-210-3p is upregulated in CC, and its level is closely correlated with FIGO stage, tumor differentiation, and lymphatic metastasis in CC patients. Besides, miRNA-210-3p produces a pronounced diagnostic efficacy, so it can be utilized as a novel hallmark for diagnosing CC and predicting the disease progression.
机译:目的:本研究的目的是检测宫颈癌(CC)组织中MicroRNA-210-3P(miRNA-210-3P)的表达水平及其临床意义。患者和方法:通过逆转录酶 - 聚合酶链反应测试MiRNA-210-3P,CC组织,正常宫颈组织和宫颈上皮内瘤瘤(CIN)组织(CIN I,CINI和CINII)的表达水平(CINI,CINI和CINII)(RT -PCR)。分析了分析了分析了MiRNA-210-3P水平与CC患者临床数据的关系。此外,引入了接收器操作特征(ROC),用于评估CC中miRNA-210-3P的诊断潜力。结果:结果表明,相对于正常宫颈组织和CIN组织的CC组织中miRNA-210-3P水平较高。其表达与CC患者的年龄,病理亚型和肿瘤大小无关。然而,MiRNA-210-3P水平与CC中的偶像阶段,肿瘤分化和淋巴转移密切相关。基于所描述的ROC,MiRNA-210-3P能够区分CC来自正常宫颈组织和CIN组织。结论:MiRNA-210-3P在CC中上调,其水平与CC患者中的FIGO阶段,肿瘤分化和淋巴结转移密切相关。此外,miRNA-210-3P产生明显的诊断疗效,因此可以用作诊断CC并预测疾病进展的新型标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号